CRISPR Therapeutics AG

CRISPR Therapeutics AG

Indicator
IND Enabling
Phase I
Phase II
Phase III
Type 1 Diabetes, T1D (NCT05210530)
Sponsors:
CRISPR Therapeutics
Indicator
IND Enabling
Phase I
Phase II
Phase III
T-Cell Lymphoma, (NCT04502446)
Sponsors:
CRISPR Therapeutics AG
Indicator
IND Enabling
Phase I
Phase II
Phase III
Beta-Thalassemia, BT, (NCT03655678)
Sponsors:
Vertex Pharmaceuticals Inc.
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Renal Cell Carcinoma, RCC, (NCT04438083)
Sponsors:
CRISPR Therapeutics AG
Indicator
IND Enabling
Phase I
Phase II
Phase III
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Sickle Cell Disease, SCD, (NCT03745287)
Sponsors:
Vertex Pharmaceuticals
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Multiple Myeloma, MM, (NCT04244656)
Sponsors:
CRISPR Therapeutics AG
Indicator
IND Enabling
Phase I
Phase II
Phase III
close
Search CRISPR Medicine